Free Trial

Heron Therapeutics (HRTX) SEC Filings & 10K Form

Heron Therapeutics logo
$1.73 +0.01 (+0.58%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.72 -0.01 (-0.87%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Heron Therapeutics SEC Filings

DateFilerForm TypeView
02/20/2025
12:51 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
4:40 PM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 4/A
02/04/2025
4:23 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4/A
02/04/2025
4:27 PM
Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
Form 4/A
02/04/2025
4:30 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4/A
02/04/2025
4:34 PM
Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
Form 4/A
02/04/2025
4:37 PM
Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
Form 4/A
02/04/2025
11:43 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
11:44 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
11:44 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
10:58 AM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
10:48 AM
Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
10:41 AM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
10:32 AM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
10:33 AM
Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
8:17 AM
Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:32 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:15 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:06 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:05 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:15 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
8:32 AM
Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
11/06/2024
1:08 PM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
11:41 AM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2024
4:09 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
10/21/2024
2:49 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
2:53 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:35 PM
Heron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/22/2024
8:44 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:54 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:32 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:44 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
3:43 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
1:21 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:34 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
10:08 AM
Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
05/29/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
1:33 PM
Heron Therapeutics (Filer)
Form DEF 14A
Has Trump finally met his match? (Ad)

Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?

Click here for his emergency broadcast...
04/29/2024
1:36 PM
Heron Therapeutics (Filer)
Form ARS
04/19/2024
4:48 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:02 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:21 PM
Heron Therapeutics (Filer)
Form PRE 14A
04/19/2024
3:34 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:32 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HRTX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners